In the increasingly competitive global medical aesthetics market, successful institutions rely not only on exquisite skills but also on reliable product partners. Choosing a supplier means purchasing a commodity. Choosing a "growth engine" means embarking on a journey towards higher profit margins, stronger customer loyalty and a broader market reputation.
This article will deeply analyze our cooperation case with a high-end medical aesthetics center in Europe, revealing how they made breakthrough progress in the field of mid-facial rejuvenation and achieved significant business growth by introducing AOMA Facefill LD 2ml, the premium HA filler.
Seek differentiated advantages and reliable product support
This clinic in Europe has long been renowned for offering natural and high-end treatment outcomes. However, when confronted with the common demand of midface volume loss, they have been constantly seeking a product that can perfectly balance safety, durability and natural effects.
The chief injection physician of the clinic shared her needs:
Our customer base has extremely strict requirements for the effect. They are eager to improve the sagging and depression of the middle face, but are extremely afraid of overly heavy or unnatural shaping effects due to excessive "filling". We need a cohesive HA gel, which must have excellent cohesion and be able to precisely support deep tissues.
Why Choose AOMA Facefill LD 2ml?
After undergoing rigorous sample testing, qualification review and clinical evaluation, it was decided to select AOMA Facefill LD 2ml as the core product for facial lifting. Its decisions are based on the following key characteristics:
● Outstanding gel cohesion
AOMA Facefill LD 2ml is a true cohesive HA gel. The three-dimensional network structure formed through advanced cross-linking technology ensures that the gel forms a whole after injection rather than being scattered. This provides a physical basis for achieving the natural lip augmentation technique and precise mid-face lifting, effectively avoiding diffusion and distortion.
● Outstanding safety and reversibility
The product is made from FDA-approved hyaluronic acid filler materials and adheres to the strictest production standards. More importantly, its reversible dermal filler feature provides ultimate security for physicians and clients.
The chief injection physician emphasized: "Knowing that in very rare cases, if necessary, we can quickly dissolve the filler through hyaluronidase has given us great confidence to boldly carry it out."
● Long-lasting and natural efficacy
Clinical observation data show that AOMA Facefill LD 2ml is a long lasting hyaluronic acid filler whose effect usually lasts for 9-12 months. Its texture is soft and it has excellent compatibility with tissues. It can effectively stimulate the regeneration of its own collagen, achieving a natural and seamless effect.
● Enhanced Comfort
Our formulation combines lidocaine with the filler to minimize needle-related discomfort from the first prick to the final touch. This means shorter chair time, calmer patients, and a more tolerable experience for chin, cheek, and jawline injections. Clinicians report higher patient satisfaction and lower anxiety scores in pre-treatment surveys.
● Natural-Looking Results
The HA gel is engineered for cohesive spreading and natural movement with facial expressions. By preserving elasticity and avoiding abrupt transitions, results mimic youthful volume without a “plugged” appearance. This yields harmonious contours in chin, cheek, and jawline areas, with customizable density for each patient’s baseline.
● Safe & Dissolvable
The product uses inactivated, non-animal-derived components with a clear reversal pathway. If needed, hyaluronidase can safely dissolve the filler, offering an added layer of reassurance for both patients and clinicians. The material is rigorously tested for biocompatibility and low risk of immune reactions, supporting responsible use across diverse skin types.
● Proven Effectiveness
This stat reflects real-world patient-reported outcomes from post-treatment surveys and clinical follow-ups. In addition to aesthetics, many patients note improved skin hydration and subtle firming in treated zones. We provide ongoing outcome tracking, enabling clinicians to tailor treatment intervals and achieve consistent, life-like results.
Clinical Practice and Effect Verification: The Art of Facial Rejuvenation
Indications: Mid-facial volume loss, mild skin laxity, improvement of nasolabial folds.
Product used: AOMA Facefill LD 2ml
Treatment process
The chief injection physician uses deep periosteal and subcutaneous tissues for precise injection, taking advantage of the high cohesion of the product to provide effective support. She particularly praised its smooth push-in feel, easy control and convenient shaping of the ideal outline.
The rheological properties of this gel are well-suited for projects that require structural remodeling, such as jawline contouring with HA and mid-face lift. It is like the moderately tough clay in a sculptor's hand, allowing you to precisely create the structure you desire."
Comparison of therapeutic effects
Postoperative precautions (provided by the clinic) :
● Avoid applying makeup or touching the injection area within 24 hours after treatment.
●Avoid high-temperature environments (such as saunas and high-temperature yoga) and strenuous exercise within a week.
● As per the doctor's advice, gentle massage may be necessary to make the gel distribute more evenly.
● Arrange a follow-up visit in four weeks for an effect evaluation.
Growth Outcomes of Partners: Business value Exceeding expectations
After introducing AOMA Facefill LD 2ml, the chief injectable physician gains more than just the product itself:
The average transaction value has increased: Due to the provision of more advanced and effective treatment plans, the average transaction value of facial rejuvenation projects has risen by approximately 25%.
Enhanced customer loyalty: Satisfied customers have led to higher repurchase rates and referral rates, with the proportion of existing customers introducing new ones increasing by 15%.
Conclusion: Embark on your journey of profit growth
This case clearly demonstrates that a successful medical aesthetics institution and an outstanding product partner form a symbiotic and mutually beneficial "growth alliance". With the quality of its premium HA filler, the precision of its cohesive HA gel, and the enduring charm of its long lasting hyaluronic acid filler, AOMA Facefill LD 2ml It has become a secret weapon to help our global partners stand out in the market competition.
Are you also ready to upgrade your supply chain into a true "growth engine"?
Contact AOMA World Overseas Sales Team immediately to obtain detailed clinical data of AOMA Facefill LD 2ml, OEM/ODM policies and regional agency plans, and jointly start a mutually beneficial and win-win partnership.
